Fig 2 Use of any antireflux drugs at baseline and at follow-up among participants with chronic gastro-oesophageal reflux disease who were randomised to or selected surgical or medical treatment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.